Long-term safety and efficacy of tocilizumab, an anti-interleuk in(IL)-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis(the STREAM study) : evidence of safety and efficacy in a 5-year extension study.
Long-term safety and efficacy of tocilizumab, an anti-interleuk in(IL)-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis(the STREAM study) : evidence of safety and efficacy in a 5-year extension study.
复制标题
托珠单抗（一种抗白细胞介素（IL）-6 受体单克隆抗体）在类风湿性关节炎患者单一疗法中的长期安全性和有效性（STREAM 研究）：一项为期 5 年的扩展研究的安全性和有效性证据。
DOI：
--
复制
发表时间：
2009
期刊：
影响因子：
--
通讯作者：
Azuma J.
中科院分区：
文献类型：
--
作者：
Nishimoto N;Miyasaka N;Yamamoto K;Kawai S;Takeuchi T;Azuma J.
